Drooid Logo
Back to story perspectives

Full Breakdown

Scotland Implements Newborn Screening for Spinal Muscular Atrophy

3/23/2026, 9:54:56 AM

Introduction to New Screening Initiative

Scotland has become the first region in the UK to introduce screening for Spinal Muscular Atrophy (SMA) in newborns, a rare genetic condition that leads to progressive muscle weakness and can significantly reduce life expectancy without treatment. The initiative, which began on March 23, 2023, involves a heel prick test administered to all babies, allowing for early identification and treatment of SMA. This pilot program aims to inform the UK screening committee about the efficacy of such testing.

Background and Context

SMA affects approximately three to four babies annually in Scotland. The condition was brought into the public eye by singer Jesy Nelson, whose twin daughters were diagnosed with SMA type 1, a more severe form of the disease. Nelson's advocacy has led to a petition that garnered over 100,000 signatures, prompting a debate in the House of Lords regarding the necessity of SMA screening across the UK.

Key Figures and Groups

  • Grayce Pearson: A three-year-old girl diagnosed with SMA type 2, whose parents, Tony and Carrie, have been vocal advocates for early screening.
  • Neil Gray: Scotland's Health Secretary, who announced the SMA screening initiative.
  • Giles Lomax: Chief Executive of SMA UK, who emphasized the significance of this milestone for the SMA community.
  • Jesy Nelson: Former Little Mix member, whose personal experience with her daughters' SMA diagnosis has spurred national attention and advocacy for screening.

Official Statements and Responses

Health Secretary Neil Gray stated, "This investment demonstrates our commitment to early detection through our screening programme," highlighting the potential for life-changing early treatment. Giles Lomax remarked that the new screening represents an important advancement for the SMA community, enabling affected babies to grow up without the complexities associated with untreated SMA.

Criticism and Opposition

Despite the positive reception of the screening initiative, some parents and advocates have expressed concerns about the timing and implementation of such programs. They argue that earlier awareness and action could have mitigated the challenges faced by families like that of Grayce Pearson, who experienced delays in diagnosis and treatment.

Verbatim Quotes

  • "As soon as that baby is born, if the parents find out their children have got SMA they can start gene therapy and show little to no symptoms." — Tony Pearson, Grayce's father.
  • "This milestone represents an important step forward for the SMA community." — Giles Lomax, Chief Executive of SMA UK.
  • "You have no idea how much this means to me and the SMA community." — Jesy Nelson, on the impact of her advocacy.

What's Next

The pilot program in Scotland will be monitored to assess its effectiveness, with results expected to influence future decisions regarding SMA screening across the UK. The ongoing advocacy from figures like Jesy Nelson may further shape the national conversation around newborn screening for SMA and other genetic conditions.